Related Experiment Videos
Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals
1Centre for Medicines Research, Carshalton, Surrey, UK.
Adverse Drug Reactions and Toxicological Reviews
|January 1, 1991
Summary
Experts propose flexible guidelines for reproductive and developmental toxicity testing in new drug development, aiming to reduce animal use and satisfy global regulatory authorities.
Area of Science:
- Pharmacology
- Toxicology
- Drug Development
Background:
- A 1991 workshop convened experts to address reproductive and developmental toxicity testing for new drugs.
- The goal was to establish unified guidelines acceptable to international regulatory bodies and scientists.
Framework:
- A consensus emerged favoring flexible guidelines based on current scientific knowledge.
- The proposed framework emphasizes minimizing animal use in toxicity testing.
- Consideration was given to a European proposal for new guidelines.
Implementation:
- Several acceptable study designs for reproductive and developmental toxicity were proposed.
- Strategies include reducing study duration, size, and animal numbers for low-hazard drugs.
- Detailed justification for chosen study designs is crucial, considering drug properties and clinical use.
Implications:
- The workshop discussions aim to form the basis for harmonized pharmaceutical toxicity testing.
- The findings will be shared with regulatory agencies and industry groups for consideration and potential adoption.